Oxford BioDynamics plc (OBD) Ordinary 1p Shares

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Oxford BioDynamics awarded $0.91m US PACT grant
31 August 2021 12:48
(Sharecast News) - Oxford BioDynamics has been awarded an FNIH Partnership for Accelerating Cancer Therapies (PACT) grant, it announced on Tuesday, to use its 'EpiSwitch' diagnostic platform for...
-
Oxford Biodynamics inks agreement with Agilent Technologies for EpiSwitch kit
31 March 2021 08:05
(Sharecast News) - Biotechnology company Oxford BioDynamics has signed a supply and resale agreement with US firm Agilent Technologies for the manufacture and sale of its new EpiSwitch Explorer Array Kit.
-
Oxford BioDynamics names Matthew Wakefield as chairman
14 December 2020 09:29
(Sharecast News) - Biotechnology company Oxford BioDynamics appointed a new chairman on Monday.
-
Oxford BioDynamics losses widen in first half
16 June 2020 13:15
(Sharecast News) - Biotechnology company Oxford BioDynamics reported a fall in revenue to £0.2m in its interim results on Tuesday, from £0.6m a year earlier.
-
Director dealings: Oxford BioDynamics chair ups stake
14 May 2020 16:01
(Sharecast News) - Oxford BioDynamics revealed on Thursday that interim chairman Stephen Diggle had acquired 30,000 ordinary shares in the AIM-listed biotechnology firm via his interest in Vulpes Testudo Fund.
-
Director dealings: Oxford Biodynamics interim chairman ups stake
11 December 2019 16:11
(Sharecast News) - Oxford Biodynamics revealed on Wednesday that interim chairman Stephen Diggle had purchased 18,309 ordinary shares in the AIM-listed biotechnology firm.
Company announcements Announcements
-
US reimbursement code for EpiSwitch® CiRT
5 July 2022 07:00
Oxford Biodynamics
-
Director/PDMR Shareholding
1 July 2022 16:13
Oxford Biodynamics
-
Half-year Report
28 June 2022 07:00
Oxford Biodynamics
-
EpiSwitch® CiRT now available in the UK
21 June 2022 07:00
Oxford Biodynamics
-
Notice of Interim Results Webinar
17 June 2022 07:00
Oxford Biodynamics
-
Notice of Results
15 June 2022 07:00
Oxford Biodynamics
-
OBD EpiSwitch® CiRT well received at ASCO 2022
14 June 2022 07:00
Oxford Biodynamics
-
Director/PDMR Shareholding
20 May 2022 15:50
Oxford Biodynamics
-
PDMR Dealing / Grant of Share Options
20 May 2022 07:00
Oxford Biodynamics
-
PDMR Dealing / Grant of Share Options
13 May 2022 15:57
Oxford Biodynamics
-
OBD to present CiRT clinical utility data at ASCO
5 May 2022 07:00
Oxford Biodynamics
-
Director/PDMR Shareholding
28 April 2022 10:54
Oxford Biodynamics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2022. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.